Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT) | MicrobiomeTrials← Back to trialsNCT07381205
Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)
RecruitingOBSERVATIONAL
Trial Details
Start: 2027-01-15Est. Completion: 2028-02
Enrollment target: 85 participants Locations- O'Neal Comprehensive Cancer Center at UAB, Birmingham, Alabama, United States
Other microbiome trials you might be interested in
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAMSinusoidal Obstruction Syndrome (SOS)HSCT Engraftment
Allogeneic hematopoietic stem cell transplantation (HSCT) is a life-saving treatment for people with severe blood-relate…
Milan, ItalyEst. completion Dec 31, 2026
Transplant Associated Microangiopathy TAM
This was a randomized, SoC-controlled, open-label, multi-center study in patients with TAM after hematopoietic precursor…
Chapel Hill, United StatesCompleted Feb 10, 2017